Financial Advocates Investment Management’s Calumet Specialty Products CLMT Stock Holding History

Financial Advocates Investment Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,193	Closed	-$169K	–	775
2022 Q3	$169K	Buy	+13,193	New	+$189K	0.01%	704

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return

DMKJ

David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Financial Advocates Investment Management's CLMT Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Calumet Specialty Products (CLMT) in Q4 2022, closing a stake of 13,193 shares — an estimated $169K sold.

Financial Advocates Investment Management first reported a position in CLMT in Q3 2022 and held it in 1 quarter. The position peaked at $169K in Q3 2022. 72 funds tracked by Wall St. Rank hold CLMT as of Q4 2022.

Financial Advocates Investment Management reported no remaining Calumet Specialty Products position as of Q4 2022 after selling out during the quarter.
Financial Advocates Investment Management sold 13,193 Calumet Specialty Products shares in Q4 2022, an estimated $169K.
Financial Advocates Investment Management first reported a position in Calumet Specialty Products in Q3 2022 and held it in 1 quarter.
Financial Advocates Investment Management's Calumet Specialty Products position peaked at $169K in Q3 2022.
72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.